# PMV Pharmaceuticals, Inc.: Form 8-K, filed Aug 8, 2024

- Company: [PMV Pharmaceuticals, Inc.](/companies/pmvp.md) (CIK 1699382)
- Form: 8-K
- Filed: 2024-08-08
- Accepted by EDGAR: Aug 8, 2024, 12:00 ET
- Period: 2024-08-05
- Accession: 0000950170-24-093345
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1699382/000095017024093345/pmvp-20240805.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1699382/000095017024093345/

## Items reported

- Item 1.02: Termination of a material agreement
- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1699382/000095017024093345/pmvp-20240805.htm

Filed Aug 8, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-093345. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.